Takeda Pharmaceutical Co Ltd (TKPHF) Times Interest Earned (2017 - 2026)
Takeda Pharmaceutical (TKPHF) posted quarterly Times Interest Earned of -$3.15 for Q2 2026, down 83.16% year-over-year from -$18.74 in Q2 2025, and down 67.92% quarter-over-quarter from -$1.88 in Q1 2026.
Takeda Pharmaceutical Co Ltd (TKPHF) Times Interest Earned (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$3.15 for Q2 2026.
- In Q2 2026, Times Interest Earned fell 83.16% year-over-year to -$3.15; the TTM figure through Jun 2026 stood at -$0.76 (up 53.52% YoY), while the FY2026 annual figure was $0.02, down 98.93% from the prior year.
- Times Interest Earned for Q2 2026 stood at -$3.15, down from -$1.88 in the prior quarter.
- The five-year high for Times Interest Earned was $7.66 in Q4 2025, with the low at -$3.15 in Q2 2026.
- The 5-year median for Times Interest Earned is -$1.91 (2026), against an average of -$1.33.
- The sharpest annual moves came in 2023 and 2025: Times Interest Earned tumbled 386.21% in 2023, then surged 414.74% in 2025.
- Takeda Pharmaceutical's Times Interest Earned stood at -$1.84 in 2022, then climbed by 2.3% to -$1.8 in 2023, then jumped by 182.69% to $1.49 in 2024, then soared by 414.74% to $7.66 in 2025, then slumped by 141.16% to -$3.15 in 2026.
- Business Quant data shows TKPHF's Times Interest Earned at -$3.15 in Q2 2026, -$1.88 in Q1 2026, and $7.66 in Q4 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.15 |
| Mar 31, 2026 | -1.88 |
| Dec 31, 2025 | 5.07 |
| Sep 30, 2025 | -1.35 |
| Jun 30, 2025 | -1.72 |
| Mar 31, 2025 | 1.34 |
| Dec 31, 2024 | 0.47 |
| Sep 30, 2024 | -3.26 |
| Jun 30, 2024 | -2.79 |
| Mar 31, 2024 | 1.41 |
| Dec 31, 2023 | -0.51 |
| Sep 30, 2023 | -3.79 |
| Jun 30, 2023 | -2.83 |
| Mar 31, 2023 | 1.44 |
| Dec 31, 2022 | -1.16 |
| Sep 30, 2022 | -0.96 |
| Jun 30, 2022 | -2.71 |
| Mar 31, 2022 | 2.03 |
| Dec 31, 2021 | -0.81 |
| Sep 30, 2021 | -0.93 |